Resverlogix Corp. (TSE:RVX – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Friday. The company traded as low as C$0.08 and last traded at C$0.08, with a volume of 63,264 shares. The stock had previously closed at C$0.09.
Resverlogix Price Performance
The company has a debt-to-equity ratio of -82.47, a quick ratio of 0.04 and a current ratio of 0.04. The company’s fifty day moving average price is C$0.09 and its 200 day moving average price is C$0.10. The firm has a market capitalization of C$27.54 million, a price-to-earnings ratio of -2.00 and a beta of -0.11.
Resverlogix Company Profile
Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.
Featured Articles
- Five stocks we like better than Resverlogix
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
